Skip to content

Clinical trials

Phase 2 Pituitary Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pituitary Diseases Phase: Phase 2 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20112
20121
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Endeavor Biomedicines, Inc.1
Memorial Sloan Kettering Cancer Center1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Novartis Pharmaceuticals1
Phoenix VA Health Care System1
RECORDATI GROUP1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pituitary Diseases7
Pituitary Neoplasms2
Adenoma, Islet Cell1
Adrenocortical Hyperfunction1
Cushing Syndrome1
Eunuchism1
Glioma1
Hypogonadism1
Hypothyroidism1
Laryngeal Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.